Intersect ENT, Inc. updated revenue guidance for the second fiscal quarter ending June 30, 2020. The the company updated its second quarter revenue outlook it provided on its first quarter conference call from an 85-90% decline from prior year revenue to a revised estimate of approximately 70-75% decline from prior year revenue, and perhaps better.